Inventor of
TREATMENT OF EROSIVE HAND OSTEOARTHRITIS
Patent application(s)
WO2024015748
( 18 January 2024 )
Microbial compositions for treating joint inflammation
Patent application(s)
WO2024160742
( 08 August 2024 )
DIAGNOSTICS AND USE OF QUORUM SENSING MOLECULES IN MUSCLE WASTING
Patent application(s)
WO2021089764
( 14 May 2021 )
Granted patent(s)
EP4055389
( 11 September 2024 )
MEANS AND METHODS TO TREAT INFLAMMATION-ASSOCIATED DISORDERS OR CONDITIONS
Patent application(s)
WO2017220802
( 28 December 2017 )
Granted patent(s)
EP3474870
( 27 July 2022 )
Anti-cancer therapy using a leptin antagonist and an iNKT-cell activator
Patent application(s)
WO2017207040
( 07 December 2017 )
Sphingamide Compounds and Methods for Binding iNKT Cells
Patent application(s)
WO2017083830
( 18 May 2017 )
Granted patent(s)
EP3374028
( 26 May 2021 )
MICROBIAL MARKER IN SPONDYLOARTHRITIS
Patent application(s)
WO2017109059
( 29 June 2017 )
Granted patent(s)
EP3394289
( 26 March 2025 )
A METHOD OF TREATING JOINT DISEASE
Patent application(s)
WO2016050796
( 07 April 2016 )
Granted patent(s)
EP3201229
( 09 September 2020 )
A method of treating bone disease
Patent application(s)
WO2015150326
( 08 October 2015 )
Granted patent(s)
EP3126393
( 11 September 2019 )
GALACTOPYRANOSYL DERIVATIVES USEFUL AS MEDICAMENTS
Patent application(s)
WO2014001204
( 03 January 2014 )
Granted patent(s)
EP3296309
( 07 August 2019 )
GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
Patent application(s)
WO2010094711
( 26 August 2010 )
Granted patent(s)
EP2399134
( 02 April 2014 )
GDF15 as differential marker for spondyloarthropathy
Patent application(s)
WO2010094709
( 26 August 2010 )
Granted patent(s)
EP2399133
( 02 October 2013 )
CARBOXYALKYLATED CYCLODEXTRIN POLYSULFATES USEFUL AS MEDICAMENTS T-STOP (Transfer)
Patent application(s)
WO2010031876
( 25 March 2010 )
Markers of matrix gene expression and cellular differentiation in chondrocytes
Patent application(s)
WO2009049913
( 23 April 2009 )
A scoring system to monitor natural or drug-modified disease progression in "erosive osteoarthritis
Patent application(s)
WO2010010193
( 28 January 2010 )
Granted patent(s)
EP2308027
( 03 April 2013 )
Combination therapy using tumour necrosis factor and an alfa-galactosyl ceramide
Patent application(s)
WO2008101951
( 28 August 2008 )
Granted patent(s)
EP2117583
( 22 May 2013 )